Showing 1 - 8 of 8
According to economic theory, health insurance raises medical care consumptions by inducing ex-post moral hazard behavior, it is to say the purchase of health care that individual value below their production cost. Nevertheless, among the economists community, some suggest that these additional...
Persistent link: https://www.econbiz.de/10010795042
This paper derives the properties of the discount rate that should be applied to a public-sector project when the affected population has heterogeneous degrees of impatience. We show that, for any distribution of discount rates, the social discount rate has the following properties: it decreases...
Persistent link: https://www.econbiz.de/10010707601
We address the problem of a social planner who, as in Weitzman (2001), gathers data on discount rates and wants to infer the socially efficient consumption discount rate. We propose an equilibrium approach and we analyse the expression and the properties of the resulting equilibrium discount...
Persistent link: https://www.econbiz.de/10010709027
Rationnel Les études médicoéconomiques sont rares dans l'arthrose. Son traitement par acide hyaluronique conduit-il à un surcoût ? Méthodes Étude observationnelle, multicentrique, longitudinale de type « avant–après » évaluant les conséquences médicoéconomiques d'un traitement...
Persistent link: https://www.econbiz.de/10011071956
Introduction Medicoeconomic data on treatments for osteoarthritis are scant. We investigated the impact of hyaluronic acid therapy on the cost of management of knee osteoarthritis. Our primary objective was to compare medical costs (admissions, outpatient visits, investigations, and treatments)...
Persistent link: https://www.econbiz.de/10011072923
The standard literature on the value of life relies on Yaari’s (1965) model, which includes an implicit assumption of risk neutrality with respect to life duration. To overpass this limitation, we extend the theory to a simple variety of nonadditively separable preferences. The enlargement we...
Persistent link: https://www.econbiz.de/10011166331
The recently published "Survival and Ventricular Enlargement" (SAVE), prospective controlled trial over 4 years including over 2,000 patients, has shown that long-term treatment with captopril reduced cardiovascular mortality (- 19%) and morbidity in patients with post-infarction left...
Persistent link: https://www.econbiz.de/10011265513
In this study, we tried to estimate the economic potential benefit of the use of fluoxetine (PROZACR 20 mg, Lilly) versus tricyclic antidepressants (TCAs) in depression of mild to moderate intensity. Fluoxetine has demonstrated, in controlled studies, significantly lower rates of side-effects...
Persistent link: https://www.econbiz.de/10011265522